27838742|t|Delicaflavone induces autophagic cell death in lung cancer via Akt / mTOR / p70S6K signaling pathway
27838742|a|Searching for potential anticancer agents from natural sources is an effective strategy for developing novel chemotherapeutic agents. In this study, data supporting the in vitro and in vivo anticancer effects of delicaflavone, a rarely occurring biflavonoid from Selaginella doederleinii, were reported. Delicaflavone exhibited favorable anticancer properties, as shown by the MTT assay and xenograft model of human non-small cell lung cancer in male BALB/c nude mice without observable adverse effect. By transmission electron microscopy with acridine orange and Cyto-ID®Autophagy detection dyes, Western blot analysis, and RT-PCR assay, we confirmed that delicaflavone induces autophagic cell death by increasing the ratio of LC3-II to LC3-I, which are autophagy-related proteins, and promoting the generation of acidic vesicular organelles and autolysosomes in the cytoplasm of human lung cancer A549 and PC-9 cells in a time - and dose-dependent manner. Delicaflavone downregulated the expression of phospho-Akt, phospho-mTOR, and phospho-p70S6K in a time - and dose-dependent manner, suggesting that it induced autophagy by inhibiting the Akt / mTOR / p70S6K pathway in A549 and PC-9 cells. Delicaflavone is a potential anticancer agent that can induce autophagic cell death in human non-small cell lung cancer via the Akt / mTOR / p70S6K signaling pathway. Delicaflavone showed anti-lung cancer effects in vitro and in vivo. Delicaflavone induced autophagic cell death via Akt / mTOR / p70S6K signaling pathway. Delicaflavone did not show observable side effects in a xenograft mouse model. Delicaflavone may represent a potential therapeutic agent for lung cancer. Delicaflavone showed anti-lung cancer effects in vitro and in vivo. Delicaflavone induced autophagic cell death via Akt / mTOR / p70S6K signaling pathway. Delicaflavone did not show observable side effects in a xenograft mouse model. Delicaflavone may represent a potential therapeutic agent for lung cancer.
27838742	0	13	Delicaflavone	T121	C1254351
27838742	14	21	induces	T169	C0205263
27838742	22	43	autophagic cell death	T043	C1326207
27838742	47	58	lung cancer	T191	C0684249
27838742	63	66	Akt	T044	C1515844
27838742	69	73	mTOR	T044	C1515673
27838742	76	82	p70S6K	T116,T126	C0073337
27838742	83	100	signaling pathway	T044	C0037080
27838742	115	124	potential	T080	C3245505
27838742	125	142	anticancer agents	T109,T121	C0003392
27838742	148	163	natural sources	T033	C0449416
27838742	170	179	effective	T080	C1704419
27838742	204	209	novel	T080	C0205314
27838742	210	233	chemotherapeutic agents	T121	C0729502
27838742	243	248	study	T062	C2603343
27838742	250	254	data	T078	C1511726
27838742	270	278	in vitro	T080	C1533691
27838742	283	290	in vivo	T082	C1515655
27838742	291	309	anticancer effects	T033	C0243095
27838742	313	326	delicaflavone	T121	C1254351
27838742	347	358	biflavonoid	T109	C0596577
27838742	364	388	Selaginella doederleinii	T002	C1210298
27838742	405	418	Delicaflavone	T121	C1254351
27838742	429	438	favorable	T080	C3640814
27838742	439	449	anticancer	T033	C0243095
27838742	450	460	properties	T070	C0243178
27838742	478	487	MTT assay	T062	C2986858
27838742	492	507	xenograft model	T050	C1520166
27838742	511	516	human	T016	C0086418
27838742	517	543	non-small cell lung cancer	T191	C0007131
27838742	547	551	male	T032	C0086582
27838742	552	568	BALB/c nude mice	T015	C0025929
27838742	588	602	adverse effect	T046	C0559546
27838742	607	639	transmission electron microscopy	T059	C0678118
27838742	645	660	acridine orange	T109,T130	C0001185
27838742	665	682	Cyto-ID®Autophagy	T043	C0004391
27838742	693	697	dyes	T130	C0013343
27838742	699	711	Western blot	T059	C0949466
27838742	712	720	analysis	T062	C0936012
27838742	726	738	RT-PCR assay	T063	C1709846
27838742	758	771	delicaflavone	T121	C1254351
27838742	772	779	induces	T169	C0205263
27838742	780	801	autophagic cell death	T043	C1326207
27838742	805	815	increasing	T169	C0442808
27838742	829	835	LC3-II	T116,T123	C3711208
27838742	839	844	LC3-I	T116,T123	C3714087
27838742	856	882	autophagy-related proteins	T116,T123	C4277731
27838742	888	897	promoting	T052	C0033414
27838742	902	912	generation	T052	C3146294
27838742	916	943	acidic vesicular organelles	T026	C0029219
27838742	948	961	autolysosomes	T026	C0230822
27838742	969	978	cytoplasm	T026	C0010834
27838742	988	999	lung cancer	T191	C0684249
27838742	1000	1004	A549	T025	C4277577
27838742	1009	1019	PC-9 cells	T025	C0007634
27838742	1025	1029	time	T079	C0040223
27838742	1036	1050	dose-dependent	T081	C1512045
27838742	1059	1072	Delicaflavone	T121	C1254351
27838742	1073	1086	downregulated	T044	C0013081
27838742	1091	1116	expression of phospho-Akt	T033	C2697945
27838742	1118	1130	phospho-mTOR	T116,T123	C0033684
27838742	1136	1150	phospho-p70S6K	T116,T123	C0033684
27838742	1156	1160	time	T079	C0040223
27838742	1167	1181	dose-dependent	T081	C1512045
27838742	1190	1200	suggesting	T078	C1705535
27838742	1209	1216	induced	T169	C0205263
27838742	1217	1226	autophagy	T043	C0004391
27838742	1230	1240	inhibiting	T052	C3463820
27838742	1245	1248	Akt	T044	C1515844
27838742	1251	1255	mTOR	T044	C1515673
27838742	1258	1264	p70S6K	T116,T126	C0073337
27838742	1265	1272	pathway	T044	C0037080
27838742	1276	1280	A549	T025	C4277577
27838742	1285	1295	PC-9 cells	T025	C0007634
27838742	1297	1310	Delicaflavone	T121	C1254351
27838742	1316	1325	potential	T080	C3245505
27838742	1326	1342	anticancer agent	T109,T121	C0003392
27838742	1352	1358	induce	T169	C0205263
27838742	1359	1380	autophagic cell death	T043	C1326207
27838742	1384	1389	human	T016	C0086418
27838742	1390	1416	non-small cell lung cancer	T191	C0007131
27838742	1425	1428	Akt	T044	C1515844
27838742	1431	1435	mTOR	T044	C1515673
27838742	1438	1444	p70S6K	T116,T126	C0073337
27838742	1445	1462	signaling pathway	T044	C0037080
27838742	1464	1477	Delicaflavone	T121	C1254351
27838742	1485	1509	anti-lung cancer effects	T033	C0243095
27838742	1510	1518	in vitro	T080	C1533691
27838742	1523	1530	in vivo	T082	C1515655
27838742	1532	1545	Delicaflavone	T121	C1254351
27838742	1546	1553	induced	T169	C0205263
27838742	1554	1575	autophagic cell death	T043	C1326207
27838742	1580	1583	Akt	T044	C1515844
27838742	1586	1590	mTOR	T044	C1515673
27838742	1593	1599	p70S6K	T116,T126	C0073337
27838742	1600	1617	signaling pathway	T044	C0037080
27838742	1619	1632	Delicaflavone	T121	C1254351
27838742	1657	1669	side effects	T046	C0879626
27838742	1675	1696	xenograft mouse model	T050	C1520166
27838742	1698	1711	Delicaflavone	T121	C1254351
27838742	1728	1737	potential	T080	C3245505
27838742	1738	1755	therapeutic agent	T073	C0304231
27838742	1760	1771	lung cancer	T191	C0684249
27838742	1773	1786	Delicaflavone	T121	C1254351
27838742	1794	1818	anti-lung cancer effects	T033	C0243095
27838742	1819	1827	in vitro	T080	C1533691
27838742	1832	1839	in vivo	T082	C1515655
27838742	1841	1854	Delicaflavone	T121	C1254351
27838742	1863	1884	autophagic cell death	T043	C1326207
27838742	1889	1892	Akt	T044	C1515844
27838742	1895	1899	mTOR	T044	C1515673
27838742	1902	1908	p70S6K	T116,T126	C0073337
27838742	1909	1926	signaling pathway	T044	C0037080
27838742	1928	1941	Delicaflavone	T121	C1254351
27838742	1966	1978	side effects	T046	C0879626
27838742	1984	2005	xenograft mouse model	T050	C1520166
27838742	2007	2020	Delicaflavone	T121	C1254351
27838742	2037	2046	potential	T080	C3245505
27838742	2047	2064	therapeutic agent	T073	C0304231
27838742	2069	2080	lung cancer	T191	C0684249